Results 11 to 20 of about 1,287,660 (290)

Association between admission anemia and long-term mortality in patients with acute myocardial infarction: results from the MONICA/KORA myocardial infarction registry

open access: yesBMC Cardiovascular Disorders, 2018
Background Previous studies have shown that the presence of anemia is associated with increased short- and long-term outcomes in patients with acute myocardial infarction (AMI).
Miriam Giovanna Colombo   +7 more
doaj   +1 more source

Epidemiology and Management of ST‐Segment–Elevation Myocardial Infarction in Patients With COVID‐19: A Report From the American Heart Association COVID‐19 Cardiovascular Disease Registry

open access: yesJournal of the American Heart Association: Cardiovascular and Cerebrovascular Disease, 2022
Background Early reports from the COVID‐19 pandemic identified coronary thrombosis leading to ST‐segment–elevation myocardial infarction (STEMI) as a complication of COVID‐19 infection.
Ankeet S. Bhatt   +11 more
doaj   +1 more source

Admission serum potassium concentration and long-term mortality in patients with acute myocardial infarction: results from the MONICA/KORA myocardial infarction registry

open access: yesBMC Cardiovascular Disorders, 2017
Background Conflicting with clinical practice guidelines, recent studies demonstrated that serum potassium concentrations (SPC) of ≥4.5 mEq/l were associated with increased mortality in patients with acute myocardial infarction (AMI). This study examined
Miriam Giovanna Colombo   +7 more
doaj   +1 more source

Case Report: Familial Pseudohyperkalemia Due to Red Blood Cell Membrane Leak in a Chinese Patient

open access: yesFrontiers in Medicine, 2022
Hyperkalemia is a critical condition requiring careful evaluation and timely intervention. Many conditions could manifest as pseudohyperkalemia and it's important to differentiate them as inappropriate potassium-lowering therapy might lead to detrimental
Weijue Xiong   +6 more
doaj   +1 more source

Incidence and predictors of left ventricular function change following ST-segment elevation myocardial infarction

open access: yesFrontiers in Cardiovascular Medicine, 2023
AimThe purpose of the study was to assess the incidence and predictors of left ventricular function change in patients with ST-segment elevation myocardial infarction (STEMI) undergoing primary PCI.Methods312 patients with STEMI who received primary ...
Chuanfen Liu   +14 more
doaj   +1 more source

Efficacy and Safety of Low-Dose Colchicine after Myocardial Infarction.

open access: yesNew England Journal of Medicine, 2019
BACKGROUND Experimental and clinical evidence support the role of inflammation in atherosclerosis and its complications. Colchicine is an orally administered, potent antiinflammatory medication that is indicated for the treatment of gout and pericarditis.
J. Tardif   +24 more
semanticscholar   +1 more source

Identification of monocyte-associated genes as predictive biomarkers of heart failure after acute myocardial infarction

open access: yesBMC Medical Genomics, 2021
Background Acute myocardial infarction (AMI) is a major contributor of heart failure (HF). Peripheral blood mononuclear cells (PBMCs), mainly monocytes, are the essential initiators of AMI-induced HF.
Qixin Chen   +5 more
doaj   +1 more source

Two cases of splenic infarction due to torsion of wandering spleen requiring laparoscopic splenectomy in adolescent girls [PDF]

open access: yesPediatric Emergency Medicine Journal, 2020
Wandering spleen is a rare condition in which the spleen is not found in its usual location or presentation. Its vascular pedicle can be twisted easily, and compromised vasculature of spleen.
Soo-Hong Kim   +2 more
doaj   +1 more source

Efficacy and Safety of Adding Ezetimibe to Statin Therapy Among Women and Men: Insight From IMPROVE‐IT (Improved Reduction of Outcomes: Vytorin Efficacy International Trial)

open access: yesJournal of the American Heart Association: Cardiovascular and Cerebrovascular Disease, 2017
BackgroundIMPROVE‐IT (Improved Reduction of Outcomes: Vytorin Efficacy International Trial) showed that adding the nonstatin ezetimibe to statin therapy further reduced cardiovascular events in patients after an acute coronary syndrome. In a prespecified
Eri Toda Kato   +9 more
doaj   +1 more source

Strategy for endovascular treatment of a patient with combined coronary and carotid artery atherosclerosis: a case report

open access: yesКардиоваскулярная терапия и профилактика, 2023
Treatment of patients with combined coronary and carotid artery atherosclerosis is a difficult task due to the increased risk of surgical intervention in this cohort of patients.
F. B. Shukurov   +4 more
doaj   +1 more source

Home - About - Disclaimer - Privacy